- Home
- MAG vs IDYA Comparison
MAG vs IDYA Comparison
Compare MAG & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAG
- IDYA
- Stock Information
- Founded
- MAG N/A
- IDYA 2015
- Country
- MAG Canada
- IDYA United States
- Employees
- MAG N/A
- IDYA N/A
- Industry
- MAG Precious Metals
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- MAG Basic Materials
- IDYA Health Care
- Exchange
- MAG Nasdaq
- IDYA Nasdaq
- Market Cap
- MAG 2.2B
- IDYA 1.9B
- IPO Year
- MAG N/A
- IDYA 2019
- Fundamental
- Price
- MAG $20.91
- IDYA $21.54
- Analyst Decision
- MAG Buy
- IDYA Strong Buy
- Analyst Count
- MAG 3
- IDYA 13
- Target Price
- MAG $18.83
- IDYA $53.42
- AVG Volume (30 Days)
- MAG 2.2M
- IDYA 1.1M
- Earning Date
- MAG 08-01-2025
- IDYA 08-05-2025
- Dividend Yield
- MAG 1.93%
- IDYA N/A
- EPS Growth
- MAG 57.48
- IDYA N/A
- EPS
- MAG 0.88
- IDYA N/A
- Revenue
- MAG N/A
- IDYA $7,000,000.00
- Revenue This Year
- MAG N/A
- IDYA $101.20
- Revenue Next Year
- MAG N/A
- IDYA $286.70
- P/E Ratio
- MAG $23.55
- IDYA N/A
- Revenue Growth
- MAG N/A
- IDYA N/A
- 52 Week Low
- MAG $11.29
- IDYA $13.45
- 52 Week High
- MAG $21.83
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- MAG 68.85
- IDYA 62.23
- Support Level
- MAG $20.70
- IDYA $21.08
- Resistance Level
- MAG $21.69
- IDYA $22.37
- Average True Range (ATR)
- MAG 0.45
- IDYA 0.92
- MACD
- MAG -0.15
- IDYA -0.09
- Stochastic Oscillator
- MAG 71.68
- IDYA 61.72
About MAG MAG Silver Corporation
MAG Silver Corp is a Canadian mining company. It is focused on advancing high-grade, district-scale precious metals projects in the Americas. The Company's principal asset is in the Juanicipio Mine located in Zacatecas, Mexico, which produced around 4,000 tonnes per day commercially. The company is also Interested in the Larder project. Its operations are Juanicipio, Deer Trail, and Larder. The Juanicipio Mine recognizes silver, gold, lead, and zinc revenue from concentrate sales.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.